GuiArte: Usefulness of ICG Angiography-Guided Thyroidectomy for Preserving Parathyroid Function

Sponsor
Hospital Universitari de Bellvitge (Other)
Overall Status
Recruiting
CT.gov ID
NCT05573828
Collaborator
(none)
394
2
2
38.7
197
5.1

Study Details

Study Description

Brief Summary

Transient and/or permanent hypoparathyroidism is the most frequent complication after total thyroidectomy. The identification of the parathyroid glands and a correct dissection during thyroidectomy have been postulated as key factors for their preservation and, consequently, to prevent hypoparathyroidism. The use of indocyanine green (ICG) fluorescence has reliably predicted parathyroid glands functionality in the immediate postoperative period. Recently, it is proposed that showing the vascular map of the parathyroid glands before performing the thyroidectomy by means of ICG angiography prevent the development of postoperative hypoparathyroidism.

The goal of this multicentric study is to demonstrate that the preservation of the function of parathyroid glands is greater with use of arteriography than without.

Patients will be divided in two groups. In the study group, the vascular map with ICG of parathyroid glands will be showed before performing the lobectomy. Once the lobectomy is done, the function of the glands will be assessed. Whereas in the control group, arteriography with ICG will only be carried out in order to check their function at the end of the lobectomy.

Researchers will compare the study group and the control group to see which one present the lowest taxes of postoperative hypoparathyroidism.

Condition or Disease Intervention/Treatment Phase
  • Procedure: ICG angiography to show vascular map of parathyroid glands
N/A

Detailed Description

To assess the appearance of postoperative hypoparathyroidism, a systematic determination of PTH and corrected calcium values will be carried out the morning after the intervention.

It will be considered that there is hypoparathyroidism when the patient presents symptoms of hypocalcaemia, when he has required the administration of calcium and/or vitamin D prior to this determination or when he presents corrected calcium values < 8 mg/dL.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
394 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Usefulness of ICG Angiography-Guided Thyroidectomy for Preserving Parathyroid Function. GuiArte Multicentric Randomized Study.
Actual Study Start Date :
Oct 11, 2022
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Angiography group

Patients undergoing initially ICG angiography guided thyroidectomy to identify the vessels feeding the parathyroid glands and then, post-thyroidectomy ICG angiography to predict immediate parathyroid function.

Procedure: ICG angiography to show vascular map of parathyroid glands
Using ICG angiography guided thyroidectomy to identify the vessels feeding the parathyroid glands and then perform the thyroidectomy. After it, ICG angiography is done to predict immediate parathyroid functio

No Intervention: Control group

Patients who underwent post-thyroidectomy ICG angiography to predict immediate parathyroid gland function by scoring the degree of fluorescence of the parathyroid glands

Outcome Measures

Primary Outcome Measures

  1. Rate of participants with postoperative hypocalcemia [1 year]

    Comparison of postoperative hypocalcemia between the two groups. It is considered hypocalcemia in the presence of symptoms of hypocalcemia or less than 1.8mmol/L in asymptomatic patients.

Secondary Outcome Measures

  1. Rate of participants with severe and permanent hypocalcemia [1 year]

    Comparison of the occurrence of severe and permanent hypocalcemia after total thyroidectomy between the two groups. Severe hypocalcemia is considered when vitamin D is added to the treatment with calcium. Permanent hypocalcemia is defined when it lasts more than 12 months.

  2. Number of parathyroid glands identified and preserved [1 year]

    Comparison of the number of parathyroid glands identified, left in situ and with an ICG score of 2 after total thyroidectomy between the two groups. The outcomes are recorded with a number from 0 to 4 to each item.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients ≥ 18 years of age with a surgical indication for total thyroidectomy with or without central cervical lymph node dissection due to thyroid pathology.

  • The patient or their guardian, where applicable, has the capacity to understand the study and agrees to participate in it, signing the corresponding informed consent document.

Exclusion Criteria:
  • Previous thyroid or parathyroid surgery

  • Severe hepatic dysfunction

  • Renal dysfunction

  • Allergy or intolerance to ICG or iodine dyes

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pablo Moreno Llorente Hospitalet de Llobregat Barcelona Spain 08907
2 Hospital UIniversitari de Bellvitge L'Hospitalet De Llobregat Barcelona Spain 08907

Sponsors and Collaborators

  • Hospital Universitari de Bellvitge

Investigators

  • Principal Investigator: Pablo Moreno, Hospital Universitari de Bellvitge

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Pablo Moreno Llorente, Head of Endocrine Surgery, Hospital Universitari de Bellvitge
ClinicalTrials.gov Identifier:
NCT05573828
Other Study ID Numbers:
  • PR161/21
First Posted:
Oct 10, 2022
Last Update Posted:
Jan 20, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Pablo Moreno Llorente, Head of Endocrine Surgery, Hospital Universitari de Bellvitge
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 20, 2023